Zemler Wu Sherman
VP PHARM STRAT & BUS DEV, BILH PHARM at BETH ISRAEL LAHEY HEALTH PHARMACY INC · MA · Healthcare
$403K
Peak Total Compensation
3
Years Tracked
5x
vs. Median Household
Zemler Wu Sherman has appeared in compensation disclosures over 3 years of available data (2020–2024). Total compensation changed from $244,393 to $403,052 - a 64.9% increase.
Peak total compensation of $403,052 equals 5x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2024 | BETH ISRAEL LAHEY HEALTH PHARMACY INC | VP PHARM STRAT & BUS DEV, BILH PHARM | $367,817 | $35,235 | $403,052 |
| 2021 | BETH ISRAEL LAHEY HEALTH PHARMACY INC | VP PHARMACY STRATEGY AND BUSINESS DEVELOPMENT | $244,710 | $32,185 | $276,895 |
| 2020 | BIDMC PHARMACY INC | BILH VP | $197,854 | $46,539 | $244,393 |
Peers at BETH ISRAEL LAHEY HEALTH PHARMACY INC
| Name | Title | Peak Comp. |
|---|---|---|
| Kevin Tabb, MD | CEO (EX-OFF) (CEO, BILH) | $5.4M |
| Michael Rowan | TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH | $4.7M |
| Steven P Fischer | DIRECTOR, TREASURER | $1.7M |
| Cindy Rios | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | $1.7M |
| Steven Fischer | BILH CFO, TRUSTEE, TREASURER (EX-OFFICIO) | $1.4M |
| Jamie Katz, ESQ | CLERK (EX-OFF); GENERAL COUNSEL BILH | $1.3M |
| Robert Fields, MD | CHAIR&TTEE (CHIEF CLIN OFF, BILH) | $1.3M |
| Jess Dejesus | PRES/TTEE (EX-OFF); CHIEF PHARM OFF | $910K |
| Efstathios Antoniades | TRUSTEE | $681K |
| Richard Fernandez | TRUSTEE | $670K |
Email Alerts
Get notified about Zemler Wu Sherman
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →